MedPath

APOTHECA MARKETING PTE LTD

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

84

HSA:84

Drug Approvals

DIGOKERN TABLETS 0.25MG

Approval Date
Sep 10, 2024
HSA

PEXARITE 500 POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/VIAL

Approval Date
Oct 30, 2023
HSA

PLERISTEM SOLUTION FOR INJECTION 20MG/ML

Approval Date
Oct 10, 2023
HSA

IRNIZET 100 CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/5ML

Approval Date
May 30, 2023
HSA

KOACT 1000 FILM-COATED TABLETS 875MG/125MG

Approval Date
Jan 11, 2023
HSA

DUTABIT PLUS 0.5/0.4 CAPSULES 0.5MG/0.4MG

Approval Date
Nov 1, 2022
HSA

ANASOMA 1 FILM-COATED TABLETS 1MG

Approval Date
Oct 5, 2022
HSA

TELFOCUS 80 TABLETS 80MG

Approval Date
Sep 1, 2022
HSA

TELFOCUS 40 TABLETS 40MG

Approval Date
Sep 1, 2022
HSA

CIATUFF 20 FILM-COATED TABLETS 20MG

Approval Date
Apr 6, 2022
HSA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.